...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>World Journal of Gastroenterology >Positron emission tomography/computed tomography with ~(18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma
【24h】

Positron emission tomography/computed tomography with ~(18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma

机译：〜（18）F-氟脱氧葡萄糖的正电子发射断层扫描/计算机断层扫描可确定肝细胞癌门静脉中的肿瘤生长或血栓形成

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Patients suffering from hepatocellular carcinoma (HCC) with tumor thrombus in the portal vein generally have a poor prognosis. Portal vein tumor thrombus must be distinguished from portal vein blood thrombus, and this identification plays a very important role in management of HCC. Conventional imaging modalities have limitations in discrimination of portal vein tumor thrombus. The application of positron emission tomography (PET) with ~(18)F-fluorodeoxyglucose (~(18)F-FDG) for discrimination between tumor extension and blood thrombus has been reported in few cases of HCC, while portal tumor thrombosis and portal vein clot identified by ~(18)F-FDG PET/CT in HCC patients has not been reported so far. We present two HCC cases, one with portal vein tumor thrombus and one thrombosis who were identified with ~(18)F-FDG PET/CT. This report illustrates the complimentary value of combining the morphological and functional imaging in achieving a correct diagnosis in such clinical situations.
机译：患有门静脉肿瘤血栓的肝细胞癌（HCC）患者通常预后较差。必须将门静脉肿瘤血栓与门静脉血栓区别开来，这种鉴别在肝癌的管理中起着非常重要的作用。常规的成像方式在门静脉肿瘤血栓的鉴别上有局限性。已有报道在少数HCC病例中应用〜（18）F-氟脱氧葡萄糖（〜（18）F-FDG）进行正电子发射断层扫描（PET）来区分肿瘤扩展和血栓，而门脉肿瘤血栓和门静脉迄今为止，尚无关于〜（18）F-FDG PET / CT在HCC患者中鉴定出的凝块的报道。我们提出了2例HCC病例，其中1例经〜（18）F-FDG PET / CT鉴定为门静脉肿瘤血栓和1例血栓形成。该报告说明了在这种临床情况下，将形态学和功能性成像相结合对正确诊断具有补充价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号